Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 51

Results For "NDA"

5510 News Found

FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion
News | June 09, 2026

FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion

Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California


Wegovy pill smashes past 3mn prescriptions in under six months in US
News | June 09, 2026

Wegovy pill smashes past 3mn prescriptions in under six months in US

The company said Wegovy hit its first one million prescriptions within 12 weeks of availability


Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide
News | June 09, 2026

Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide

The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format


Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials
Clinical Trials | June 09, 2026

Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials

The results come from post-hoc analyses of more than 1,500 women enrolled in the Phase 3 ATTAIN-1 and ATTAIN-2 trials, presented at the American Diabetes Association’s 86th Scientific Sessions


Merck signs MoU with CSIR-IICT to strengthen industry-academia ties
R&D | June 09, 2026

Merck signs MoU with CSIR-IICT to strengthen industry-academia ties

The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation


Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial
News | June 09, 2026

Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial

Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter


Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours
Healthcare | June 09, 2026

Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours

Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology


Yashoda Medicity gets DGME approval for brain stem death certification committee
Hospitals | June 09, 2026

Yashoda Medicity gets DGME approval for brain stem death certification committee

The newly constituted committee will facilitate timely brain stem death certification, supporting transparent organ donation processes and expanding opportunities for patients awaiting transplants


DENSTAR project launched to fast-track dengue vaccine licensure in Africa
Healthcare | June 09, 2026

DENSTAR project launched to fast-track dengue vaccine licensure in Africa

Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa